Overview: Pan Fungal Detection PCR TestIntroduction: The Pan Fungal Detection PCR Test detects fungal DNA to diagnose fungal infections, causing skin or lung issues. Following 2023 IDSA guidelines, it uses PCR for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in molecular pathology for patients with suspected fungal infections, such as dermatophytosis or pulmonary fungal disease.
Other Names: Pan Fungal PCR Assay, Fungal DNA Detection Test.
FDA Status: Laboratory-developed test (LDT), meeting molecular pathology standards for diagnostic accuracy.
Historical Milestone: Fungal PCR testing began in the 1990s with fungal infection research. PCR methods improved in the 2010s, enhancing diagnostic precision.
Purpose: Detects fungal DNA to diagnose fungal infections, guides treatment, and evaluates patients with skin or lung issues.
Test Parameters: 1. Fungal DNA Presence
Pretest Condition: No fasting required. Collect whole blood, tissue, BAL, sputum, CSF, or saliva. Report history of skin issues, lung issues, or fungal infection symptoms.
Specimen: Whole Blood (EDTA, 2-5 mL), Tissue (sterile container, 0.5-2 cma³), Bronchoalveolar Lavage (sterile container, 5-10 mL), Sputum (sterile container, 5-10 mL), CSF (sterile container, 1-2 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document skin issues, lung issues, or history of immunosuppression. Include current medications, especially antifungals.
Consent: Written consent required, detailing the tests purpose, fungal infection implications, and risks of sample collection.
Procedural Considerations: Uses PCR to detect fungal DNA. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for fungal infection diagnosis.
Factors Affecting Result Accuracy: Low DNA yield or improper sample storage can affect results. Contamination may reduce specificity.
Clinical Significance: Positive fungal DNA confirms infection, guiding antifungal therapy. Negative results may require culture confirmation.
Specialist Consultation: Consult an infectious disease specialist or dermatologist for result interpretation and treatment planning.
Additional Supporting Tests: Fungal culture, KOH prep, or imaging (CT/chest X-ray) to confirm fungal infection diagnosis.
Test Limitations: Not all fungi are detectable by PCR; clinical correlation is needed. Sample quality affects sensitivity.
References: IDSA Fungal Guidelines, 2023; Clinical Infectious Diseases, Perfect JR, 2022.
